Cargando…

Diagnostic Value of (11)C-Methionine (MET) and (18)F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis

We retrospectively evaluated the usefulness of combined measurement of L-methyl-[(11)C]methionine (MET) and 3'-deoxy-3'-[(18)F]fluorothymidine (FLT) positron emission tomography (PET) in the differential diagnosis between recurrent gliomas and necrotic lesions. Twenty-one patients with hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shishido, Hajime, Kawai, Nobuyuki, Miyake, Keisuke, Yamamoto, Yuka, Nishiyama, Yoshihiro, Tamiya, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712687/ https://www.ncbi.nlm.nih.gov/pubmed/24213238 http://dx.doi.org/10.3390/cancers4010244

Ejemplares similares

Diagnostic value of PET/CT with (11)C-methionine (MET) and (18)F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
por: Ogawa, Tomoya, et al.
Publicado: (2020)

Comparison of 4′-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging
por: Toyota, Yasunori, et al.
Publicado: (2015)

Usefulness of FDG, MET and FLT-PET Studies for the Management of Human Gliomas
por: Miyake, Keisuke, et al.
Publicado: (2012)

Temporal and spatial changes in reactive astrogliosis examined by (18)F-THK5351 positron emission tomography in a patient with severe traumatic brain injury
por: Hatakeyama, Tetsuhiro, et al.
Publicado: (2021)

Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria
por: Miyake, Keisuke, et al.
Publicado: (2020)

Fractal analysis of (11)C-methionine PET in patients with newly diagnosed glioma
por: Maeda, Yukito, et al.
Publicado: (2021)

Usefulness of Positron Emission Tomographic Studies for Gliomas
por: MIYAKE, Keisuke, et al.
Publicado: (2016)

(18)F-FDG PET in the Diagnosis and Treatment of Primary Central Nervous System Lymphoma
por: Kawai, Nobuyuki, et al.
Publicado: (2013)

Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
por: Suzuki, Kenta, et al.
Publicado: (2021)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
por: Nikaki, Alexandra, et al.
Publicado: (2019)

Diagnostic and Prognostic Significance of Methionine Uptake and Methionine Positron Emission Tomography Imaging in Gliomas
por: Palanichamy, Kamalakannan, et al.
Publicado: (2017)

Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
por: Sharma, R., et al.
Publicado: (2016)

Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)

(18)F-fluorothymidine PET imaging in gliomas: an update
por: Nikaki, Alexandra, et al.
Publicado: (2017)

Insufficiency of Positron Emission Tomography and Magnetic Resonance Spectroscopy in the Diagnosis of Intravascular Lymphoma of the Central Nervous System
por: Kawai, Nobuyuki, et al.
Publicado: (2012)

The Positron Emission Tomography Tracer 3’-Deoxy-3’-[(18)F]Fluorothymidine ([(18)F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice
por: Wiehr, Stefan, et al.
Publicado: (2016)

Comparison of (11)C-Methionine, (11)C-Choline, and (18)F-Fluorodeoxyglucose-Positron Emission Tomography for Distinguishing Glioma Recurrence from Radiation Necrosis
por: TAKENAKA, Shunsuke, et al.
Publicado: (2014)

An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography (18)F-FLT PET/CT in Prostate Adenocarcinoma
por: Kairemo, Kalevi, et al.
Publicado: (2017)

Usefulness of (11)C-methionine positron emission tomography for detecting intracranial ameloblastic carcinoma: A case report
por: TEMPAKU, AKIRA, et al.
Publicado: (2014)

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
por: Santoni, Matteo, et al.
Publicado: (2014)

Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas
por: Haining, Zhen, et al.
Publicado: (2012)

Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (Met-PET) findings in patients with glioblastoma
por: Hirono, Seiichiro, et al.
Publicado: (2019)

Preliminary (19)F-MRS Study of Tumor Cell Proliferation with 3′-deoxy-3′-fluorothymidine and Its Metabolite (FLT-MP)
por: Ko, In Ok, et al.
Publicado: (2017)

Resveratrol represses YKL-40 expression in human glioma U87 cells
por: Zhang, Wei, et al.
Publicado: (2010)

Clinical value of 3'-deoxy-3'-[(18)F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancer
por: Alwadani, Bandar, et al.
Publicado: (2021)

A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show (18)F-Fluorothymidine “Flare” on Positron Emission Tomography
por: Aravind, Preetha, et al.
Publicado: (2023)

Preoperative Texture Analysis Using (11)C-Methionine Positron Emission Tomography Predicts Survival after Surgery for Glioma
por: Manabe, Osamu, et al.
Publicado: (2021)

Early reduction in tumour [(18)F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone
por: Trigonis, Ioannis, et al.
Publicado: (2014)

Effect of quantitative values on shortened acquisition duration in brain tumor (11)C-methionine PET/CT
por: Morimoto, Masatoshi, et al.
Publicado: (2021)

Synthesis and evaluation of 3′-[(18)F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[(18)F]fluorothymidine-5′-monophosphate
por: Brickute, D., et al.
Publicado: (2021)

Combination of Magnetic Resonance Spectroscopy and (11)C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma
por: Kudulaiti, Nijiati, et al.
Publicado: (2019)

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2020)

(18)F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study
por: Christensen, Tine Nøhr, et al.
Publicado: (2020)

IMG-02. USEFUL DIAGNOSIS OF PEDIATRIC CYSTIC BRAIN TUMORS USING MULTIPLE POSITRON EMISSION TOMOGRAPHY STUDIES
por: Miyake, Keisuke, et al.
Publicado: (2020)

Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study
por: Nguyen, Nghi C., et al.
Publicado: (2018)

Differentiation of astrocytoma between grades II and III using a combination of methionine positron emission tomography and magnetic resonance spectroscopy
por: Yano, Hirohito, et al.
Publicado: (2023)

Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses
por: Turcotte, Eric, et al.
Publicado: (2007)

NI-01 CONTRAST-ENHANCED MRI AND POSITRON EMISSION TOMOGRAPHY FOR DISTINGUISHING THE GRADE OF GLIOMA
por: Takei, Hiroaki, et al.
Publicado: (2019)

Correlation of 4′-[methyl-(11)C]-thiothymidine PET with Gd-enhanced and FLAIR MRI in patients with newly diagnosed glioma
por: Norikane, Takashi, et al.
Publicado: (2021)

NI-08 Utility of multiple positron emission tomography tracers in the diagnosis of brain tumors according to the 2016 World Health Organization classification
por: Miyake, Keisuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s73gpmmctivhhhgupne0pm9si4